Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
Mabs|February 5, 2014
The ErbB2-targeting antibody trastuzumab and the small-molecule SRC inhibitor saracatinib synergistically inhibit ErbB2-overexpressing gastric cancerSiqi Han, Yanchun Meng, Qing Tong, et al.
BMB Reports|October 31, 2009
Development and characterization of a fully functional small anti-HER2 antibodyJie Gao, Bohua Li, Huimei Li, et al.
Biomaterials|May 1, 2012
Chemotherapy for gastric cancer by finely tailoring anti-Her2 anchored dual targeting immunomicellesWei Li, He Zhao, Weizhu Qian, et al.
Molecular Pharmaceutics|July 6, 2016
In-Depth Characterization of a Pro-Antibody-Drug Conjugate by LC-MSBoning Liu, Huaizu Guo, Junjie Zhang, et al.
Mabs|February 14, 2015
Generation and characterization of a target-selectively activated antibody against epidermal growth factor receptor with enhanced anti-tumor potencyYun Yang, Qingcheng Guo, Mao Xia, et al.
Cellular and Molecular Life Sciences : CMLS|October 26, 2013
Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomasLili Li, Jianming Ying, Xin Tong, et al.
Mabs|March 28, 2014
Combating non-Hodgkin lymphoma by targeting both CD20 and HLA-DR through CD20-243 CrossMabLei Zhao, Feiyue Xie, Xin Tong, et al.
Cancer Research|September 19, 2013
Bispecific antibody to ErbB2 overcomes trastuzumab resistance through comprehensive blockade of ErbB2 heterodimerizationBohua Li, Yanchun Meng, Lei Zheng, et al.
Oncotarget|December 30, 2014
TGF-β1 induces epigenetic silence of TIP30 to promote tumor metastasis in esophageal carcinomaFangfang Bu, Xing Liu, Jingjing Li, et al.
Oncotarget|December 16, 2016
Sp1-mediated transcriptional activation of miR-205 promotes radioresistance in esophageal squamous cell carcinomaFei Pan, Hui Mao, Fangfang Bu, et al.
Pageof 22